According to a press release from X-Rx Inc., a privately-held American biotechnology company, the Food and Drug Administration has accepted the company's Investigational New Drug (IND) application for X-165, an…
According to a publication from Breastcancer.org, black women are more likely than others to develop triple-negative breast cancer at some point in their lives. A study published by the journal…
According to a publication from PR Newswire, CloudMedx, a technology company from Palo Alto, is touting impressive results following a simulated exam pitting human doctors against their "deep learning" Clinical…
According to a publication from PR Newswire, a team of five scientists recently had their research published by the American Journal of Kidney Diseases, suggesting that chronic kidney disease might…
In an article published by SciTech Europa, Professor Susanne Gerit Kircher with the Medical University of Vienna discusses some of the difficulties experienced by professionals on the front lines of rare…
An article originally published by CBS New York recently emphasized the importance of regular mammograms for detecting breast cancer, even in families with no history of mutated BRCA genes. What…
An article recently published by the Washington Post is highlighting a few of the risks associated with fertility treatments that some doctors feel are de-emphasized by existing medical literature. What…
According to a publication from KSPR 33, a drug that was once given away free of charge on a provisional basis to people with Lambert-Eaton myasthenic syndrome (or LEMS) is…
According to a publication from the Stamford Advocate, the Connecticut-based Alliance for Cancer Gene Therapy (or ACGT) has welcomed a new president and CEO in Kevin Honeycutt. Honeycutt has announced…
According to an article from R&D, researchers at the New York City-based Icahn School of Medicine at Mount Sinai have entered an agreement with two pharmaceutical companies to aid in…
According to a press release from Danish biotechnology company Bavarian Nordic, ten individuals with chordomas have been successfully recruited for a Phase 2 study of the drug candidate BN-Brachyury. About…
According to a publication from OncLive, the FDA has granted TG Therapeutics' experimental marginal zone lymphoma drug Umbralisib a "Breakthrough Therapy" designation. About Marginal Zone Lymphoma Marginal zone lymphoma (or…
According to a publication from BusinessWire, the Maryland-based pharmaceutical company OncoImmune, Inc. has announced successful phase 2 trial results for its acute graft versus host disease (GVHD) drug CD24Fc. Graft…
According to an article from Pharmaceutical Daily, the Seattle-based drug company Sound Pharmaceuticals is set to soon begin a phase 2 clinical study for a cystic fibrosis (CF) drug candidate…
According to an article published by Washington University of Medicine in St. Louis, scientists appear to have succeeded in slowing axon destruction in mice through standard gene therapy. Though an…
According to a publication from Stat, scientists have high hopes about "virtual repurposing" cutting drug production costs. It could also potentially mean more treatments on the market faster. Virtual Repurposing…
According to a report from ITV, a five-year-old boy from southern England has made the trip across the Bay of Biscay to Barcelona, Spain, where he is receiving an experimental…
According to an article published by R&D, scientists at Harvard have identified a new genetic clue that they suspect might be linked to the development of amyotrophic lateral sclerosis (ALS).…
According to an article from Global Banking & Financing Review, the California-based pharmaceutical company Exelixis, Inc. has announced the FDA's approval of their drug Cabometyx (cabozantinib) for patients previously diagnosed…
According to an article recently published by Forbes, one data scientist wants to explain why data science has proven to be slow at identifying particular biomarkers in medical patients. Imran…
According to an article at UIC Today, scientists at the University of Illinois at Chicago have conducted experiments suggesting graphene might be useful in diagnosing amyotrophic lateral sclerosis (ALS) or…
According to an article from PM360, Reata Pharmaceuticals has announced that its end-of-Phase 2 meeting with the Food and Drug Administration went according to plan. The American pharmaceutical company based…
According to an article at Gaucher Disease News, the first known case of a person with both Gaucher disease and severe congenital neutropenia was examined in a case study that…
According to CheckOrphan, Clinuvel Pharmaceuticals recently announced that their drug Scenesse has received a Prescription Drug User Fee Act (PDUFA) date from the FDA, set for July 8th of this…
According to an article from PM360, the French biopharmaceutical company Sanofi has announced successful results at the end of a phase 3 study of their hopeful acquired thrombotic thrombocytopenic purpura…
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
